Mercer Global Advisors
CGTX icon

Mercer Global Advisors’s Cognition Therapeutics CGTX Stock Holding History

Mercer Global Advisors’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3K Hold
15,951
– – ﹤0.01% 3597
2026
Q1 		$12.1K Hold
15,951
– – ﹤0.01% 3202
2025
Q4 		$21.5K Hold
15,951
– – ﹤0.01% 2820
2025
Q3 		$21.5K Sell
15,951
-100
-0.6% -$136 ﹤0.01% 2616
2025
Q2 		$4.97K Hold
16,051
– – ﹤0.01% 2246
2025
Q1 		$6.75K Hold
16,051
– – ﹤0.01% 2141
2024
Q4 		$11.3K Hold
16,051
– – ﹤0.01% 2110
2024
Q3 		$7.07K Sell
16,051
-79,900
-83% -$82.4K ﹤0.01% 1948
2024
Q2 		$159K Buy
95,951
+24,050
+33% +$47.9K ﹤0.01% 1827
2024
Q1 		$131K Sell
71,901
-59,050
-45% -$122K ﹤0.01% 1836
2023
Q4 		$242K Buy
130,951
+115,000
+721% +$152K ﹤0.01% 1741
2023
Q3 		$23K Hold
15,951
– – ﹤0.01% 1922
2023
Q2 		$29K Buy
+15,951
New +$33.8K ﹤0.01% 1883

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Mercer Global Advisors's CGTX Position: Q2 2026 in Review

Mercer Global Advisors held its Cognition Therapeutics (CGTX) position steady in Q2 2026 at 15,951 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

Mercer Global Advisors first reported a position in CGTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $242K in Q4 2023. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Mercer Global Advisors held 15,951 shares of Cognition Therapeutics worth $18.3K as of Q2 2026.
  • Mercer Global Advisors left its Cognition Therapeutics share count unchanged in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3597 holding.
  • Mercer Global Advisors first reported a position in Cognition Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Mercer Global Advisors's Cognition Therapeutics position peaked at $242K in Q4 2023.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.